NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 123 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $148,886 | -58.8% | 139,145 | -0.3% | 0.00% | – |
| Q2 2023 | $361,398 | -33.2% | 139,536 | +5.2% | 0.00% | – |
| Q1 2023 | $541,391 | -19.2% | 132,694 | -0.5% | 0.00% | – |
| Q4 2022 | $669,743 | -66.0% | 133,415 | -11.4% | 0.00% | – |
| Q3 2022 | $1,970,000 | +17.5% | 150,629 | +15.2% | 0.00% | – |
| Q2 2022 | $1,677,000 | -17.0% | 130,789 | -1.3% | 0.00% | – |
| Q1 2022 | $2,021,000 | -11.3% | 132,514 | +3.0% | 0.00% | – |
| Q4 2021 | $2,278,000 | -7.6% | 128,621 | +9.7% | 0.00% | – |
| Q3 2021 | $2,465,000 | +23.2% | 117,234 | +15.6% | 0.00% | – |
| Q2 2021 | $2,000,000 | -13.7% | 101,391 | +27.1% | 0.00% | – |
| Q1 2021 | $2,318,000 | -8.0% | 79,756 | -4.1% | 0.00% | -100.0% |
| Q4 2020 | $2,519,000 | +86.2% | 83,155 | -2.2% | 0.00% | – |
| Q3 2020 | $1,353,000 | -15.6% | 85,046 | +4.8% | 0.00% | – |
| Q2 2020 | $1,603,000 | +57.9% | 81,189 | -1.3% | 0.00% | – |
| Q1 2020 | $1,015,000 | -6.5% | 82,295 | +40.1% | 0.00% | – |
| Q4 2019 | $1,085,000 | +214.5% | 58,728 | +135.5% | 0.00% | – |
| Q3 2019 | $345,000 | +96.0% | 24,937 | +107.7% | 0.00% | – |
| Q2 2019 | $176,000 | – | 12,009 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenspring Associates, LLC | 1,573,357 | $47,665,000 | 61.89% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $114,111,000 | 60.06% |
| Column Group LLC | 15,396,116 | $466,502,000 | 42.31% |
| Ponoi II Management, LLC | 1,298,908 | $39,357,000 | 28.68% |
| Ponoi Management, LLC | 1,298,908 | $39,357,000 | 22.52% |
| Euclidean Capital LLC | 2,083,602 | $63,133,000 | 13.36% |
| Aquilo Capital Management, LLC | 1,005,534 | $30,463,000 | 6.33% |
| Octagon Capital Advisors LP | 75,227 | $2,279,000 | 0.79% |
| Jasper Ridge Partners, L.P. | 308,750 | $9,354,000 | 0.41% |
| Point72 Asset Management, L.P. | 1,761,157 | $53,354,000 | 0.26% |